takeaway call
galactic-hf second interim analysi rear-
view mirror increas attent ck-
initi data first cohort patient
redwood-hcm expect
multipl readout expect updat
straightforward given multipl recent updat includ announc
januari top-line data galactic-hf would acceler
studi continu plan follow second interim analysi although
baselin characterist galactic-hf present later
month two main data readout year includ galactic-hf top-line
result first cohort patient phase redwood-hcm
studi overal encourag continu make
progress four cardiac muscl program remain posit
prospect omecamtiv mecarbil ahead full data later year
takeaway manag reiter although meteor read
galact potenti applic file omecamtiv
mecarbil studi requir file compani submit result
initi market applic file even though manag believ
rational move reldesemtiv forward includ feedback
regul momentum site investig certain aspect still need
clarifi like align feedback regul much co-
fund astella potenti phase studi would begin
galactic-hf studi read cytokinet provid guidanc
includ cash revenu oper expens
model updat lower revenu partnership increas
sg expens base guidanc net result
ep chang
upcom catalyst present galactic-hf baselin characterist
march meet initi phase top-line
result galactic-hf data first cohort phase
redwood-hcm complet sad/mad cohort phase
complet enrol meteoric-hf
 unit state america
unless otherwis note metric base modelwar
consensu data provid thomson reuter estim
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
pt deriv discount cash ow analysi use discount rate
equal-weight thesi base lack
signic clinic catalyst ahead
omecamtiv mecarbil phase data
cautiou reldesemtiv
greater market share bull case
assum greater adopt omecamtiv
omecamtiv reach market
omecamtiv reach market
mecarbil sale adjust use
po om
galact studi fail product
galact studi fail product
candid advanc
candid advanc
unabl advanc product candid
trade cash value-per-share
begin reldesemtiv phase studi al
compani rational begin potenti
phase studi reldesemtiv al
galactic-hf stop earli
faster-than-expect advanc pipelin
safeti signal aris
galactic-hf termin earli futil
fund exposur held mspb inform may
inconsist may reect broader market
exposur sector total net exposur
across sector long exposur short exposur
note suffici broker suppli
consensu data metric
inform opinion research prepar co llc and/or and/or morgan
stanley mexico de bolsa de and/or canada limit use disclosur section includ morgan
stanley co llc mexico de bolsa de canada limit affili
necessari
import disclosur stock price chart equiti rate histori regard compani subject report pleas see morgan
stanley research disclosur websit www morganstanley com/researchdisclosur contact invest repres
research broadway attent research manag new york ny usa
valuat methodolog risk associ recommend rate price target referenc research report pleas contact client
support follow us/canada hong kong latin america london
singapor sydney tokyo altern may contact invest repres morgan
stanley research broadway attent research manag new york ny usa
follow analyst herebi certifi view compani secur discuss report accur express
receiv receiv direct indirect compens exchang express specif recommend view report jeffrey
unless otherwis state individu list cover page report research analyst
morgan stanley research publish accord conflict manag polici avail
www morganstanley com/institutional/research/conflictpolici portugues version polici found www morganstanley com br
import us regulatori disclosur subject compani
januari benefici own class common equiti secur follow compani cover morgan
within last month manag co-manag public offer offer secur alector inc amgen inc aprea
within last month receiv compens invest bank servic alector inc
next month expect receiv intend seek compens invest bank servic akebia
within last month receiv compens product servic invest bank servic amgen inc
within last month provid provid invest bank servic invest bank client relationship
follow compani alector inc amgen inc
within last month either provid provid non-invest bank securities-rel servic and/or past
enter agreement provid servic client relationship follow compani amgen inc beigen ltd biogen inc biomarin
 co llc make market secur alector inc
equiti research analyst strategist princip respons prepar research receiv compens base upon
variou factor includ qualiti research investor client feedback stock pick competit factor firm revenu overal invest bank
revenu equiti research analyst strategist compens link invest bank capit market transact perform morgan
stanley profit revenu particular trade desk
affili busi relat companies/instru cover research includ market make provid
liquid fund manag commerci bank extens credit invest servic invest bank sell buy
custom securities/instru compani cover research princip basi may posit debt
compani instrument discuss report trade may trade princip debt secur relat deriv
subject debt research report
certain disclosur list also complianc applic regul non-u jurisdict
